Literature DB >> 16181624

Expression of DHX32 in lymphoid tissues.

Zaman Alli1, Michael Ho, Mohamed Abdelhaleem.   

Abstract

DHX32 is a novel putative RNA helicase identified based on its downregulation in acute lymphoblastic leukemia. DHX32 gene has 12 exons, alternative usage of exons 1 and 2 results in the expression of two transcripts that differ in their 5' untranslated region (UTR), consistent with the involvement of two different promoters. In addition, exon 5 skipping results in the production of a full-length and alternatively spliced transcripts. We used transcript-specific primers in reverse transcriptase (RT)-PCR to show that the thymus and spleen express all of DHX32 transcripts. We also used immunohistochemistry to study the expression of DHX32 protein. The expression pattern of DHX32 protein in normal lymphoid tissues is variable but suggests association with state of lymphocyte activation and/or differentiation. Dysregulated expression of DHX32 is noted in some types of lymphoma compared to their normal counterpart.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181624     DOI: 10.1016/j.yexmp.2005.07.002

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  4 in total

1.  ETS1 and SP1 drive DHX15 expression in acute lymphoblastic leukaemia.

Authors:  Xiang-Lei Chen; Yuan-Hua Cai; Qiao Liu; Li-Li Pan; Shui-Ling Shi; Xiao-Li Liu; Yuan Chen; Jing-Gang Li; Jing Wang; Yang Li; Xiao-Fan Li; Shao-Yuan Wang
Journal:  J Cell Mol Med       Date:  2018-03-07       Impact factor: 5.310

2.  Up-regulation and clinical relevance of novel helicase homologue DHX32 in colorectal cancer.

Authors:  Chunling Huang; Xianming Liang; Ruxin Huang; Zhongying Zhang
Journal:  J Exp Clin Cancer Res       Date:  2009-01-22

3.  A human XPC protein interactome--a resource.

Authors:  Abigail Lubin; Ling Zhang; Hua Chen; Victoria M White; Feng Gong
Journal:  Int J Mol Sci       Date:  2013-12-23       Impact factor: 5.923

4.  Silencing of DHX32 increases the proliferation of liver cancer cells.

Authors:  Min-Jing Cai; Jian-Hui Zhu; Jian-Quan He; Zhong-Ying Zhang; Xian-Ming Liang
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.